News | January 18, 2011

Force-Sensing Ablation Catheter to be Integrated With Siemens EP Systems

January 19, 2011 – Siemens Healthcare is partnering with Endosense for the integration of the contact-force data provided by Endosense’s TactiCath force-sensing ablation catheter with Siemens’ electrophysiology (EP) solutions. The goal of the effort is to develop an all-in-one software application that allows electrophysiologists to visualize catheter-tip-to-tissue contact force within a three-dimensional anatomic heart model during catheter ablation procedures.

“The joint development project between Endosense and Siemens represents a very promising area of future advancement in the field of catheter ablation, as it will offer electrophysiologists a new platform for incorporating contact force sensing into clinical practice,” said Eric Le Royer, Endosense CEO. “An integrated, all-in-one system will deliver greater functionality and efficiency to EP labs, thereby moving Endosense another step toward our goal of improving and expanding catheter ablation for the treatment of cardiac arrhythmias.”

Endosense pioneered the field of contact force sensing in catheter ablation with its TactiCath force-sensing ablation catheter and accompanying TactiSys system. Launched in Europe in April 2010, the second generation of the novel device is now used by electrophysiologists across Europe for the treatment of atrial fibrillation (AF) and supraventricular tachycardia (SVT). In the United States the TactiCath is an investigational device in the recently launched TOCCASTAR investigational device exemption (IDE) study.

“We believe optimization of catheter-tip-to-tissue contact force bears huge potential to improve effectiveness and efficiency of electrophysiology ablation procedures. However, it is important to visualize this new parameter in relation to the 3-D anatomy of the heart and, if available, planning data,” said Martin Ostermeier, director, innovations, of the interventional X-ray business unit of Siemens Healthcare. “The goal of our joint project is to demonstrate the clinical benefits of Endosense’s TactiCath technology integrated into the advanced 3-D imaging capabilities, the syngo DynaCT cardiac of our Artis zee family of cath lab angiography systems for EP procedures.”

For more information, visit www.endosense.com, www.siemens.com/healthcare

Related Content

Trial Data Shows Positive Predictive Results for Boston Scientific HeartLogic Heart Failure Diagnostic
News | Heart Failure| October 20, 2017
October 20, 2017 — Boston Scientific announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart F
Smartphone Apps Help Patients and Providers Manage Atrial Fibrillation
News | Patient Engagement| October 19, 2017
October 19, 2017 — Novel smartphone and tablet applications for atrial fibrillation patients and healthcare professio
The Respicardia Remede System is a pacemaker-like device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with Central sleep apnea.
Technology | Heart Failure| October 18, 2017
October 18, 2017 — The U.S.
Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab| October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems| October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems| October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD)| September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Spectranetics Initiates Class I Recall for Bridge Occlusion Balloon Catheter
News | EP Lab| September 27, 2017
Spectranetics is recalling its Bridge Occlusion Balloon Catheter due to the possibility of a blocked guidewire lumen in...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Overlay Init